Related references
Note: Only part of the references are listed.The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
David C. Wedge et al.
NATURE GENETICS (2018)
Regulatory protein SrpA controls phage infection and core cellular processes in Pseudomonas aeruginosa
Jiajia You et al.
NATURE COMMUNICATIONS (2018)
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Huairui Yuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
Ni Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
Di Zhao et al.
NATURE (2017)
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
Xiangpeng Dai et al.
NATURE MEDICINE (2017)
Synthetic lethality and cancer
Nigel J. O'Neil et al.
NATURE REVIEWS GENETICS (2017)
Nuclear carbonic anhydrase 6B associates with PRMT5 to epigenetically promote IL-12 expression in innate response
Jia Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
Maria B. Olsen et al.
CELL REPORTS (2017)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg et al.
NATURE REVIEWS GENETICS (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy
Fan Xu et al.
ONCOTARGET (2016)
A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon
Dong Gao et al.
PLOS ONE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation
Nilotpal Roy et al.
GENES & DEVELOPMENT (2015)
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
Kimberly H. Kim et al.
NATURE MEDICINE (2015)
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler et al.
NATURE MEDICINE (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
Katherine C. Helming et al.
CANCER CELL (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Jun Qin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma
Guido von Figura et al.
NATURE CELL BIOLOGY (2014)
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
Petar Jelinic et al.
NATURE GENETICS (2014)
ARID1B is a specific vulnerability in ARID1A-mutant cancers
Katherine C. Helming et al.
NATURE MEDICINE (2014)
Brg1 Loss Attenuates Aberrant Wnt-Signalling and Prevents Wnt-Dependent Tumourigenesis in the Murine Small Intestine
Aliaksei Z. Holik et al.
PLOS GENETICS (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
London Pancreas Workshop 2014 Edited by Hemanth Kocher Volume 14, Issue 2, Supplement 1, Pages e1-e6 (March-April 2014) Abstracts
[Anonymous]
PANCREATOLOGY (2014)
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis
Jun Qin et al.
NATURE (2013)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
Tamara L. Lotan et al.
CLINICAL CANCER RESEARCH (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
Rita U. Lukacs et al.
CELL STEM CELL (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CEAS: cis-regulatory element annotation system
Hyunjin Shin et al.
BIOINFORMATICS (2009)
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction
Daming Gao et al.
NATURE CELL BIOLOGY (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
K Ellwood-Yen et al.
CANCER CELL (2003)
Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens
CL Jin et al.
PROSTATE (2003)
Pten dose dictates cancer progression in the prostate
LC Trotman et al.
PLOS BIOLOGY (2003)
Prostatic Intraepithelial neoplasia in genetically engineered mice
JH Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The SCF ubiquitin ligase: An extended look
PK Jackson et al.
MOLECULAR CELL (2002)
A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes
S Bultman et al.
MOLECULAR CELL (2000)
Share Paper
